Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06044831 · ClinicalTrials.gov registry record

Expanded Population Health Model Evaluation

A clinical trial of Quality of Life and Chronic Disease, sponsored by Baylor Research Institute.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT06044831: Recruiting study of Quality of Life and Chronic Disease, sponsored by Baylor Research Institute.

NCT06044831 is a study of Quality of Life and Chronic Disease that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 300 participants, below the 450-participant average among 107 other Quality of Life trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06044831, a study of Quality of Life and Chronic Disease, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the impact of a comprehensive wellness and social determinants of health intervention on cardiovascular health in a community setting of the Bonton neighborhood. Participants will not be assigned to intervention activities, but health and wellbeing indicators will be collected in relation to how they choose to participate in activities over the year.

Primary Outcome

Life's Essential 8 composite score includes 8 metrics used to measure cardiovascular health. The metrics are diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, and blood pressure. Each individual metric is scored 0-100 based on clinical thresholds and the composite score is the unweighted, aggregate of all the metrics. Scores 0-49 are considered low cardiovascular health, 50-79 moderate cardiovascular health, and 80-100 high cardiovascular hea

Interventions

  • BEHAVIORAL Expanded Population Health Model

Study Locations (1)

Texas

  • Baylor Scott & White Health and Wellness Center - Dallas

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-08-28
Est. Completion 2026-10
Baylor Research Institute

180 total trials

What NCT06044831 shows while recruiting

NCT06044831 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 450-participant average among 107 other Quality of Life trials with a reported enrollment target (33% lower).

The record links to 2 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Expanded Population Health Model is the first listed.

NCT06044831 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06044831 about?

NCT06044831 is a clinical study titled "Expanded Population Health Model Evaluation". This study will evaluate the impact of a comprehensive wellness and social determinants of health intervention on cardiovascular health in a community setting of the Bonton neighborhood. Participants will not be assigned to intervention activities, but health and wellbeing indicators will be collect...

What is the current status of trial NCT06044831?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2023-08-28. Estimated completion is 2026-10.

What conditions does trial NCT06044831 study?

This clinical trial studies the following conditions: Quality of Life, Chronic Disease.

What interventions are being tested in trial NCT06044831?

The interventions under investigation include: Expanded Population Health Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT06044831?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06044831 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06044831's enrollment target sits among peer trials

300 25th of 107 higher than 82 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06044831, the US trial registry maintained by the National Library of Medicine. NCT06044831 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.